Case Report
Copyright ©The Author(s) 2024.
World J Diabetes. Dec 15, 2024; 15(12): 2360-2369
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2360
Table 2 Summary of clinical phenotypic characteristics of familial partial lipodystrophy disease caused by PPARG mutation[11,16,24,26,34-39,42,50-62]
Domain
Gene mutation type
Manifestation
Ref.
Diabetes/insulin resistance
Hypertrigly-ceridemia
Hyper-tension
Others
LBDH449LYesYesPCOS, acanthosis nigricans, hepatocyte steatosis, no coronary arteries and other vascular diseasesDemir et al[34]
P467LYesYesYesCirrhosis and liver cancer develop in the context of non-alcoholic steatohepatitisSavage et al[24]; Barroso et al[35]
V290MYesYesYesPrimary amenorrhea, hypertrichosis, acanthosis nigricansSavage et al[24]; Barroso et al[35]
F310SYesYesFatty liver, liver dysfunction, albuminuria and diabetic peripheral neuropathyChen et al[36]
F162CYesYesHepatomegaly, metabolic steatohepatitisMelzer et al[38]
R425CYesYesLipodystrophy of the extremities and face, hirsutismAgarwal and Garg[39]
Q157GYesYesYesPolycystic ovarian syndrome, premature menopause at the age of 38, underwent hysterectomy due to fibroids at the age of 54, osteoporosis at the age of 58Lambadiari et al[42]
A261EYesYesPCOS, lipodystrophy of the extremitiesAgostini et al[16]
R308PYesYesPCOS, Nonalcoholic fatty liver diseaseAgostini et al[16]; Majithia et al[50]
K347TYesYesYesLipoatrophy of the limbs, elevated creatine kinase levels, recurrent pancreatitisMiehle et al[51]
E352QYesYesLow level of plasma leptin, hepatic steatosis, whereas funduscopy was normalCastell et al[52]
Y355XYesYesYesSteatosis hepatis, Family history of similar physical appearance, acute pancreatitisFrancis et al[53]
T356RYesYesNon-alcoholic fatty liver, dyslipidemia, and low serum adiponectin levelsMajithia et al[50]
R385XYesYesYesAcanthosis nigricans, lipodystrophy affecting gluteal, pancreatitis, cutaneous eruptive xanthomataAgostini et al[54]
P387SYesYesSevere insulin resistance, non-alcoholic fatty liver, dyslipidemia, and low serum adiponectin levelsMajithia et al[50]
F388LYesYesPolycystic ovarian disease, atrophy of gluteal fatHegele et al[11]
A417VYesYesSevere insulin resistance, non-alcoholic fatty liver, dyslipidemia, and low serum adiponectin levelsMajithia et al[50]
D424NYesYesMuscular hypertrophy was observed on the legs, slight acanthosis nigricans was present on the neck, axillae and inguinal folds, loss of subcutaneous fat from the arms, accumulation of subcutaneous fat was present in face, chin, trunk and abdomen, ovarian cystLüdtke et al[55]
L451PYesYesHirsutism, marked loss of subcutaneous fat from the extremities but truncal fat was slightly increasedBroekema et al[56]
H477LYesYesTrunk-sparing lipodystrophy, acanthosis nigricans, multiple acrochordons, an excess of subcutaneous adipose tissue in the abdomen with a decreased amount of subcutaneous adipose tissue in the patient’s lower extremitiesAkinci et al[57]
P495LYesYesSevere insulin resistance, non-alcoholic fatty liver, dyslipidemia, and low serum adiponectin levelsBarroso et al[35]
DBDY151CYesYesYesPancreatitis, cardiovascular disease, no acanthosis nigricans or hirsutismVisser et al[37]
FS138XYesBilateral cataracts, bilateral hearing impairment and peripheral neuropathyHegele et al[58]
C114RYesYesYesPCOS, hepatic steatosisAgostini et al[54]
E157DYesYesHepatic steatosis, acanthosis nigricans, hirsutism, PCOSCampeau et al[59]
C131YYesYesYesPCOS, hepatic steatosisAgostini et al[54]
G161VYesYesYesBilateral fallopian tube obstruction, eruptive xanthoma, type V dyslipidemia, pancreatitis, severe hepatic steatosisLau et al[26]
R165TYesYesYesPeripheral lipoatrophy, muscular hypertrophy, liver steatosisAuclair et al[60]
FS186XYesYesYesAcanthosis nigricansSavage et al[61]
C162WYesYesYesPCOS, hepatic steatosisAgostini et al[54]
R194WYesYesYesPCOS, acanthosis nigricansMonajemi et al[62]